Evonik Industries AG
XETRA:EVK
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Evonik Industries AG
Total Current Liabilities
Evonik Industries AG
Total Current Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Evonik Industries AG
XETRA:EVK
|
Total Current Liabilities
€3.3B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
3%
|
CAGR 10-Years
1%
|
|
|
Wacker Chemie AG
XETRA:WCH
|
Total Current Liabilities
€1.3B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
9%
|
CAGR 10-Years
1%
|
|
|
Covestro AG
XETRA:1COV
|
Total Current Liabilities
€4.2B
|
CAGR 3-Years
0%
|
CAGR 5-Years
19%
|
CAGR 10-Years
-6%
|
|
|
AlzChem Group AG
XETRA:ACT
|
Total Current Liabilities
€118.9m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
|
Symrise AG
XETRA:SY1
|
Total Current Liabilities
€1.3B
|
CAGR 3-Years
11%
|
CAGR 5-Years
15%
|
CAGR 10-Years
9%
|
|
|
U
|
Uzin Utz SE
SWB:UZU
|
Total Current Liabilities
€95.2m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
7%
|
CAGR 10-Years
8%
|
|
Evonik Industries AG
Glance View
Evonik Industries AG, a German powerhouse in the chemical industry, has carved out a prominent position by focusing on specialty chemicals that serve a plethora of industries worldwide. Unlike conventional chemical companies rooted in commodity chemicals, Evonik stands out through its innovative portfolio that includes high-performance polymers, additives, and unique formulations that enhance product efficiency across various sectors. Their operations aren’t confined to producing basic chemicals; instead, they emphasize specialized applications contributing to fields like healthcare, nutrition, resource efficiency, and smart materials. This focus enables Evonik to develop products that are integral to the functionalities of automotive parts, pharmaceuticals, animal feeds, and even consumer goods, thereby embedding themselves across the global value chain. In generating revenue, Evonik adopts a business strategy that leverages its deep expertise in research and development, alongside strategic acquisitions and partnerships. Their R&D efforts are devoted to pioneering sustainable solutions – from energy-efficient building materials to biodegradable plastics – aligning with global sustainability trends. This innovative edge helps ensure that their products not only meet current market demands but also anticipate future needs. Revenue flows largely from the sale of these specialty products, which enjoy higher margins compared to traditional chemicals due to their unique applications and value-added benefits. Additionally, Evonik's strategic geographic expansion, particularly in emerging markets, and adaptation to local customer needs further drive growth, underpinning their continued success and ability to capture value in a rapidly evolving global market.
See Also
What is Evonik Industries AG's Total Current Liabilities?
Total Current Liabilities
3.3B
EUR
Based on the financial report for Dec 31, 2025, Evonik Industries AG's Total Current Liabilities amounts to 3.3B EUR.
What is Evonik Industries AG's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 10Y
1%
Over the last year, the Total Current Liabilities growth was -18%. The average annual Total Current Liabilities growth rates for Evonik Industries AG have been -3% over the past three years , 3% over the past five years , and 1% over the past ten years .